Preclinical analyses and phase I evaluation of LY2603618 administered in combination with pemetrexed and cisplatin in patients with advanced cancer (Q38983310)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Preclinical analyses and phase I evaluation of LY2603618 administered in combination with pemetrexed and cisplatin in patients with advanced cancer |
scientific article |
Statements
1 reference
Preclinical analyses and phase I evaluation of LY2603618 administered in combination with pemetrexed and cisplatin in patients with advanced cancer (English)
1 reference
Victor J Chen
Mark Marshall
Ute Ohnmacht
Scott M Hynes
Elizabeth Kumm
H Bruce Diaz
Darlene Barnard
Farhana F Merzoug
Lysiane Huber
Lisa Kays
Philip Iversen
Beatrice Voss
Aimee Bence Lin
Nicolas Dickgreber
Thomas Wehler
20 June 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference